In 2002, Miramax Entertainment released The Magdalene Sisters, a film that portrays an interpretation of the true events experienced by four young women who were forcibly placed into a Magdalene asylum in Dublin, Ireland, in 1964. Catholic nuns ran Magdalene asylums throughout the world, where they forced women whom society deemed sexually promiscuous to perform hard labor in their laundry facilities. The film portrays the experiences of four women, Margaret, Bernadette, Rose, and Crispina, as they experienced negative treatment from the nuns and sought escape. Directed by Peter Mullan, The Magdalene Sisters provided a means to see how women, including unwed mothers, prostitutes, and those with disabilities, were affected by Magdalene laundries in Ireland.

In 1992, five maternal-infant health researchers founded Doulas of North America, later renamed DONA International to train certified birth attendants called doulas to provide care to pregnant women both before and after the birthing process. Annie Kennedy, John Kennell, Marshall Klaus, Phyllis Klaus, and Penny Simkin used the term doula, derived from the Greek word for woman servant, to describe a female birthing aide who provides non-medical emotional and physical support to laboring pregnant women. Eventually renamed DONA International, the organization has certified over 12,000 doulas as of 2017. Though the organization aims to provide a doula to everyone who wants one, there have been controversies surrounding the accessibility, affordability, and necessity of pregnant women using a doula before and after birth. DONA International is the largest doula-certifying program in the world and has created global awareness of the risks and benefits associated with using a doula during the birthing process.

Dana Louise Raphael was an anthropologist and breastfeeding advocate in the US during the twentieth century. After she was unable to breastfeed her own infant, Raphael began to research why breastfeeding was more common in other cultures than in the US. As part of that research, Raphael cofounded the Human Lactation Center, where she studied the breastfeeding habits of mothers around the world. Through that research, she coordinated with formula manufacturers to educate women on the benefits of breastfeeding and formula supplementation to reduce infant mortality in developing nations. In addition, Raphael was the first person to use the word doula to describe a childbirth support companion for laboring women. Raphael was an advocate for the acceptance of breastfeeding around the world, and asserted the importance of doula support for new mothers in the form of breastfeeding education.

In 1998, Testimony Films released the documentary Sex in a Cold Climate, which reported the true stories of four survivors from the Magdalene asylums in Ireland in the twentieth century. Magdalene asylums, also called Magdalene laundries and homes, were institutions of the Catholic Church that sought to reform women engaged in prostitution and those who birthed children out of wedlock by forcing the women to do hard labor. Directed by Steve Humphries, the documentary interlocks four survivors’ stories of how they came to inhabit a Magdalene asylum, what occurred to them there, and how they eventually freed themselves. An Irish film festival first screened the documentary, which became the inspiration for the 2002 film, The Magdalene Sisters. Sex in a Cold Climate brought attention to the stories of women who survived Magdalene asylums, which prompted additional research and eventual justice for many of the women.

William John Little was one of the first orthopedic surgeons to research congenital malformations and their causes in the nineteenth century and presented preliminary research on a condition modernly known as cerebral palsy, a condition of varying severity that affects a person’s ability to move. Little worked throughout the United Kingdom for the majority of the time he practiced medicine, and eventually founded one of the first orthopedic infirmaries, the Royal Orthopedic Hospital in London, England. Throughout his career, Little studied congenital malformations, which are medical conditions inherited before birth, as well as how certain medical circumstances during delivery affect the neonate. In 1861, he described a condition with motor, behavioral, and cognitive irregularities in neonates, linked with oxygen deprivation during birth. Little’s research on that condition, originally called Little’s disease, and modernly, spastic cerebral palsy, was one of the first accounts of cerebral palsy in infants.

To address the international Human Immunodeficiency Virus epidemic, the World Health Organization, or WHO, developed three drug treatment regimens between 2010 and 2012 specifically for HIV-positive pregnant women and their infants. WHO developed the regimens, calling them Option A, Option B, and Option B+, to reduce or prevent mother-to-child, abbreviated MTC, transmission of HIV. Each option comprises of different types and schedules of antiretroviral medications. As of 2018, WHO reported that in Africa alone about 1,200,000 pregnant women were living with untreated HIV. Those women have up to a forty-five percent chance of transmitting HIV to their offspring if they do not receive treatment. Option B+ has decreased the overall maternal mortality rates in many low- and middle-income countries, and numerous studies have supported the notion that it is the most effective of the three regimens for preventing MTC transmission of HIV.

In 2011, United Kingdom pharmaceutical company GlaxoSmithKline released Cervarix, a vaccination series protecting girls and women from two strains of Human Papillomavirus, or HPV. HPV, a sexually transmitted infection, can present in men and women without symptoms, or may cause symptoms such as genital warts. There is a link between HPV and cervical, vaginal, anal, head, neck, and face cancers, and Cervarix can reduce genital cancers in girls and women, particularly cervical cancer. Gardasil, a similar vaccination against HPV, approved by the United States Food and Drug Administration, or FDA and available in the US in June 2006 was on the market five years prior to Cervarix’s approval in October 2009. In 2014, because of the heightened cost and lesser coverage, the US market discontinued Cervarix, but as of 2019, it remains popular in Europe, especially in the United Kingdom. Cervarix is the first HPV vaccine administered in China.

Ian Hector Frazer studied the human immune system and vaccines in Brisbane, Australia, and helped invent and patent the scientific process and technology behind what later became the human papillomavirus, or HPV, vaccinations. According to the Centers for Disease Control and Prevention of the US, or CDC, HPV is the most common sexually transmitted infection, and can lead to genital warts, as well as cervical, head, mouth, and neck cancers. Frazer and virologist Jian Zhou conducted research in the 1990s to assess why women with HPV had higher rates of precancerous and cancerous cervical cells. Frazer’s research led the pharmaceutical company Merck to produce the Gardasil vaccination series, and GlaxoSmithKline to produce the Cervarix vaccination. Frazer’s research contributed to the development of HPV vaccinations that have been successful in reducing up to seventy percent of cervical cancer cases in women.